Characteristics of Immune Response to Tumor‐Associated Antigens and Immune Cell Profile in Patients With Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Characteristics of Immune Response to Tumor‐Associated Antigens and Immune Cell Profile in Patients With Hepatocellular Carcinoma

Published:2018-12-31 Issue:2 Volume:69 Page:653-665
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Inada Yuki¹,Mizukoshi Eishiro¹,Seike Takuya¹,Tamai Toshikatsu¹,Iida Noriho¹,Kitahara Masaaki¹,Yamashita Tatsuya¹,Arai Kuniaki¹,Terashima Takeshi¹,Fushimi Kazumi¹,Yamashita Taro¹,Honda Masao¹,Kaneko Shuichi¹

Affiliation:

1. Department of Gastroenterology, Graduate School of MedicineKanazawa University Kanazawa, Ishikawa Japan

Funder

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30212

Reference41 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. AASLD guidelines for the treatment of hepatocellular carcinoma

3. Sorafenib in Advanced Hepatocellular Carcinoma

4. Immunotherapeutic approaches for hepatocellular carcinoma

5. Generation of human T‐cell responses to an HLA‐A2.1‐restricted peptide epitope derived from alpha‐fetoprotein;Butterfield LH;Cancer Res,1999

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of general anesthesia combined with epidural block on stress response and shift of T helper cells in patients after cervical cancer surgery;2024-08-21

2. Small-molecule-based targeted therapy in liver cancer;Molecular Therapy;2024-08

3. Harnessing CD8⁺ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions;Clinical and Translational Medicine;2024-06-27

4. Prognostic and therapeutic potential of imbalance between PD‐1+CD8 and ICOS+Treg cells in advanced HBV‐HCC;Cancer Science;2024-06-15

5. Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti–programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinoma;Oncology and Translational Medicine;2024-06-03